ストックスクリーナーアプリを入手
43.23
5.49%
2.25
プレマーケット:
46.74
3.51
+8.12%
前日終値:
$40.98
開ける：
$41.8
24時間の取引高:
9.10M
Relative Volume:
0.68
時価総額：
$7.43B
収益：
$640.44M
当期純損益:
$-743.28M
株価収益率:
-3.8295
EPS:
-11.2888
ネットキャッシュフロー:
$-206.93M
1週間 パフォーマンス:
+0.70%
1か月 パフォーマンス:
-15.81%
6か月 パフォーマンス:
-7.09%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$41.67
$45.48
1週間の範囲:
$39.01
$45.48
52週間の値動き範囲:
$22.89
$91.45
Tempus Ai Inc Stock (TEM) Company Profile
TEM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
43.23 | 7.43B | 640.44M | -743.28M | -206.93M | -11.29 |
|
VEEV
Veeva Systems Inc
|
215.78 | 36.24B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
52.40 | 9.99B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
83.45 | 7.23B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.45 | 6.36B | 906.14M | -52.62M | 89.62M | -0.3621 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-25 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2025-02-12 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2025-02-05 | 再開されました | TD Cowen | Buy |
| 2024-12-13 | 開始されました | Wolfe Research | Outperform |
| 2024-12-09 | 開始されました | Guggenheim | Buy |
| 2024-11-11 | ダウングレード | Stifel | Buy → Hold |
| 2024-10-02 | ダウングレード | BofA Securities | Buy → Neutral |
| 2024-08-12 | 開始されました | Piper Sandler | Neutral |
| 2024-07-09 | 開始されました | BofA Securities | Buy |
| 2024-07-09 | 開始されました | JP Morgan | Overweight |
| 2024-07-09 | 開始されました | Longbow | Buy |
| 2024-07-09 | 開始されました | Loop Capital | Buy |
| 2024-07-09 | 開始されました | Morgan Stanley | Overweight |
| 2024-07-09 | 開始されました | Needham | Buy |
| 2024-07-09 | 開始されました | Stifel | Buy |
| 2024-07-09 | 開始されました | TD Cowen | Buy |
| 2024-07-09 | 開始されました | William Blair | Outperform |
すべてを表示
Tempus Ai Inc (TEM) 最新ニュース
Tempus AI partners with AstraZeneca and Pathos on oncology AI By Investing.com - Investing.com India
Tempus AI announces oncology collaboration with AstraZeneca, Pathos AI - TipRanks
Tempus Signs Expanded Strategic Agreements with AstraZeneca and Pathos to Develop the Largest Multimodal Foundation Model in Oncology - Business Wire
BTIG Initiates Coverage of Tempus AI (BMV:TEM) with Buy Recommendation - Nasdaq
Why Quantum Computing (QUBT), Nano Nuclear Energy (NNE) and Tempus AI (TEM) Are Popping Higher Today - MSN
Lobbying Update: $60,000 of TEMPUS AI INC. lobbying was just disclosed - Nasdaq
Tempus AI (TEM) Initiated at ‘Buy’ with $60 Price Target by BTIG - Yahoo Finance
Tempus AI: Cooldown Arrived (Rating Upgrade) - Seeking Alpha
BTIG Initiates Coverage of Tempus AI (TEM) with Buy Recommendation - Nasdaq
BTIG Analyst Sees Tempus AI (TEM) as “Significant Free Call Option” with 48% Upside - markets.businessinsider.com
Tempus AI Gets Bullish Boost from BTIG on Data Strength, Expansion Moves - TradingView
BTIG sets Tempus stock Buy rating with $60 target - Investing.com Australia
BTIG sets Tempus stock Buy rating with $60 target By Investing.com - Investing.com South Africa
Tempus AI initiated with a Buy at BTIG - Seeking Alpha
BTIG Initiates Tempus AI at Buy With $60 Price Target - marketscreener.com
The recent drop in prices must have disappointed Tempus AI, Inc. (NASDAQ:TEM) institutional investors who own 36% of the shares - simplywall.st
Tempus AI: Architecting the Next Era of Intelligent Diagnostics - Mitrade
Tempus: The AI Engine Powering Healthcare - Seeking Alpha
Tempus assembles advisory board to guide oncology research - Crain's Chicago Business
Tempus Unveils Advisory Board Featuring Leading Physicians From Across the U.S. - 01net
Illumina, Tempus AI partner to drive genomic testing beyond cancer - MedTech Dive
Illumina and Tempus join forces to expand genomic testing By Investing.com - Investing.com South Africa
Illumina, Tempus AI To Collaborate To Accelerate Genomic AI Innovation - Nasdaq
Illumina, Tempus AI Collaborating to Accelerate Clinical Use of Sequencing Tests - marketscreener.com
Illumina and Tempus join forces to expand genomic testing - Investing.com Australia
Illumina And Tempus Partner To Drive The Future Of Precision Medicine Through Genomic Ai Innovation - MarketScreener
Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation - Financial Times
Tempus (TEM) stock: Analysts say AI healthcare will be the next gold rush - Investorsobserver
Smart Money Is Betting Big In TEM Options - Benzinga
3 Hot New IPOs Defying the 2025 Market Slump - The Globe and Mail
Tempus AI vs. Doximity: Which AI in Healthcare Stock is a Better Buy? - Yahoo Finance
Is it safe to buy the Tempus AI stock dip now? - MSN
Cathie Wood's Thursday Plays: Healthcare AI And Crypto — Ark Scoops Up Tempus AI and Coinbase Stock Amid Trump Tariff CrashCoinbase Global (NASDAQ:COIN), ARK Innovation ETF (BATS:ARKK) - Benzinga
Beyond Tempus AI: 2 Health IT Stocks Poised For Growth In 2025 - Barchart.com
Beyond Tempus AI: 2 Health IT Stocks Poised for Growth in 2025 - Yahoo Finance
WOW!'s Senior Director of Talent Management and Senior Director - GuruFocus
Why Tempus AI Inc. (TEM) Went Down On Tuesday? - MSN
Tuesday’s 10 Worst-Performing Stocks - Insider Monkey
Cathie Wood Loads Up On $18.2 Million Worth Of Nvidia Stock, Adds $5.8 Million Worth Of Amazon Shares To Her Shopping Cart Amid Trump Tariff Upheaval - Benzinga
DnB Asset Management AS Takes $641,000 Position in Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
Tempus AI, Inc. (TEM): Among Stocks That Will Profit From AI - MSN
10 Stocks That Will Profit From AI - Insider Monkey
Wayne A.I. Frederick Sells 3,000 Shares of Tempus AI, Inc. (NASDAQ:TEM) Stock - MarketBeat
Tempus AI director Jennifer Doudna sells shares worth $30,075 - Investing.com Australia
Tempus AI director Jennifer Doudna sells shares worth $30,075 By Investing.com - Investing.com Canada
Executives at Tempus AI Conduct Stock Transactions - TradingView
Tempus Fugit Ad Nevada - The National Law Review
Tempus AI director Frederick Wayne sells $136,620 in stock By Investing.com - Investing.com Canada
Tempus Ai Inc (TEM) 財務データ
収益
当期純利益
現金流量
EPS
4.05%
大文字化:
|
ボリューム (24 時間):